Stay informed with expert insights, trends, and best practices in life sciences compliance.
Prosecutors have indicted six executives from the South Korean unit of Novartis for paying rebates to doctors so they may prescribe the company’s drugs to patients. Twenty-eight other individuals, including fifteen doctors and six medical publishers, were also part of the prosecutorial sweep. The six executives who were prosecuted include Novartis Korea chief Moon Hak-sun. […]
CBI held the 10th Annual Forum on Transparency and Aggregate Spend at the Ritz-Carlton in Washington, D.C. from 15th – 17th August, 2016. The forum provided an excellent opportunity for pharmaceutical, biotech, and medical device executives to connect and share information about best practices pertaining to Federal, State, and worldwide HCP reporting. The conference delivered […]
The relationship between the life sciences industry and healthcare professionals is complex, involving various financial transactions that can potentially influence medical decisions. To address concerns about conflicts of interest in healthcare, Congress enacted the Physician Payments Sunshine Act (PPSA) in March 2010 as part of the Patient Protection and Affordable Care Act (ACA). The Sunshine […]
In the first quarter of the year, Olympus Corp., the United States’ largest distributor of endoscopes and related equipment, agreed to pay $623.2 million to resolve criminal charges and civil claims relating to a scheme to pay kickbacks to doctors and hospitals. It was further announced that a subsidiary of the distributor will pay $22.8 […]
The U.S. Department of Justice (DOJ) doubled the penalties for False Claims Act (FCA) violations on the 1st of August, 2016. As of August 1, the penalties have been increased from $5,500 to $11,000 per claim to $10,781.40 and $21,562.80 per claim. Of course, the threat of triple damages remains in place. Announced back in […]
Since 2013, Federal regulators have stepped up scrutiny of the relationships between pharmaceutical manufacturers and healthcare providers. Considering the potential fines that are in place, this isn’t a time when companies can sit back complacently. Instead, they must dedicate this time to verifying the accuracy of their data and reporting systems so they can identify […]